Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Opthalmic Suspension Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

ClinicalTrials.gov ID: NCT06128369

Public ClinicalTrials.gov record NCT06128369. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 9:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-masked, Vehicle-controlled Study Evaluating the Efficacy and Safety of OCS-01 Ophthalmic Suspension in the Treatment of Inflammation and Pain Following Cataract Surgery

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This was a randomized, double-masked, vehicle-controlled, Phase 3 study evaluating the efficacy and safety of OCS-01 QD compared to vehicle in the treatment of inflammation and pain following cataract surgery.

Study identification

NCT ID
NCT06128369
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Oculis
Industry
Enrollment
117 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 17, 2023
Primary completion
May 1, 2024
Completion
May 8, 2024
Last update posted
Jul 29, 2026

2023 – 2024

United States locations

U.S. sites
24
U.S. states
16
U.S. cities
24
Facility City State ZIP Site status
Oculis Investigative Site Glendale California 91204
Oculis Investigative Site Inglewood California 90301
Oculis Investigative Site Newport Beach California 92663
Oculis Investigative Site Torrance California 90505
Oculis Investigative Site Tamarac Florida 33321
Oculis Investigative Site Morrow Georgia 30260
Oculis Investigative Site Northbrook Illinois 60062
Oculis Investigative Site Indianapolis Indiana 46240
Oculis Investigative Site Louisville Kentucky 40206
Oculis Investigative Site Woburn Massachusetts 01810
Oculis Investigative Site St Louis Missouri 63131
Oculis Investigative Site Washington Missouri 63090
Oculis Investigative Site Las Vegas Nevada 89145
Oculis Investigative Site Elizabeth City North Carolina 27909
Oculis Investigative Site Leland North Carolina 28451
Oculis Investigative Site Cincinnati Ohio 45242
Oculis Investigative Site Eugene Oregon 97401
Oculis Investigative Site Erie Pennsylvania 16507
Oculis Investigative Site Kingston Pennsylvania 18704
Oculis Investigative Site Nashville Tennessee 37212
Oculis Investigative Site Austin Texas 78731
Oculis Investigative Site Houston Texas 77008
Oculis Investigative Site San Antonio Texas 78229
Oculis Investigative Site Lynchburg Virginia 24502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06128369, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 29, 2026 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06128369 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →